Oxygenta Pharmaceutical share news, announcements and annual reports
BSE: 524636Pharmaceuticals & BiotechnologySmall Cap
OXYGENTA PHARMACEUTICAL LIMITED · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Oct 1994
Last close ₹47.86down ₹0.10 (0.21%)
Share price at the BSE close on 29 Oct 2026. Previous close ₹47.96.
29 Oct: open ₹48.44, high ₹48.50, low ₹47.01
52-week range of traded prices to 29 Oct 2026
₹43.00Low, 11 Jun 2026₹71.59High, 12 Aug 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹177 Cr2,423rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Net worth zero or below
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business.
- Net worth zero or below
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −15.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- Net worth zero or below
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 4,615
Oxygenta Pharmaceutical shareholder meetings
45 filed, newest first.
Aug 2026
21 Aug · Meeting
Jul 2026
30 Jul · Meeting
Dec 2025
11 Dec · Meeting
11 Dec · Meeting
11 Dec · Meeting
Nov 2025
11 Nov · Meeting
Sep 2025
19 Sep · Meeting
Aug 2025
Oct 2024
3 Oct · Meeting
Sep 2024
30 Sep · Meeting
May 2024
10 May · Meeting
9 May · Meeting
Apr 2024
Oct 2023
Sep 2023
30 Sep · Meeting
Mar 2023
Sep 2022
Jan 2022
Dec 2021
Sep 2021
8 Sep · Meeting
Dec 2020
Oct 2019
1 Oct · Meeting
Oct 2018
Sep 2018
29 Sep · Meeting
Sep 2017
29 Sep · Meeting
Oct 2016
Sep 2016
Dec 2015
1 Dec · Meeting
Register of Members & Share Transfer Books of the Company will remain closed from December 17, 2015 to December 24, 2015 (both days inclusive) ....
Oct 2014
Sep 2014
8 Sep · Meeting
Register of Members & Share Transfer Books of the Company will remain closed from September 16, 2014 to September 26, 2014 (both days inclusive) ....